We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Valneva et LimmaTech annoncent la vaccination du premier participant à l’essai d’infection contrôlée de Phase 2b du candidat vaccin tétravalent contre la shigellose S4V2 Saint Herblain (France) et...
Valneva and LimmaTech Announce First Vaccination in Phase 2b Human Challenge Study of Tetravalent Shigella Vaccine Candidate S4V2 Saint Herblain (France) and Schlieren (Zurich), November 13, 2024...
Valneva to Present and Hold Investor Meetings at Upcoming U.S. and European Healthcare Conferences Saint-Herblain (France), November 12, 2024 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a...
Valneva fera des présentations et rencontrera les investisseurs lors de conférences aux États-Unis et en Europe Saint-Herblain (France), le 12 novembre 2024 – Valneva SE (Nasdaq: VALN; Euronext...
Valneva publie ses résultats financiers pour les neuf premiers mois de l’exercice 2024 et fait un point sur ses activités Principaux éléments financiers pour les neuf premiers mois de l’exercice...
Valneva Reports Nine-Month 2024 Financial Results and Provides Corporate Updates Nine-Month Key Financial Highlights Total revenues of €116.6 million, including product sales of...
VALNEVA - Declaration of shares and voting rights: October 31, 2024 VALNEVA Declaration of shares and voting rights October 31, 2024________________________________________________________________...
VALNEVA - Déclaration d’actions et de droits de vote : 31 octobre 2024 VALNEVA Déclaration d’actions et de droits de vote 31 octobre 2024___________________________________________________________...
Valneva to Present on Chikungunya at Several Leading Scientific Conferences Saint-Herblain (France), October 21, 2024 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company...
Valneva effectuera des présentations sur le chikungunya lors de différentes conférences scientifiques de premier plan Saint-Herblain (France), le 21 octobre 2024 – Valneva SE (Nasdaq: VALN;...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.2440001 | -10.7111545215 | 2.278 | 2.31 | 2.0019999 | 99036 | 2.11376954 | DE |
4 | -0.6520001 | -24.2740171258 | 2.686 | 2.826 | 2.0019999 | 71768 | 2.36659383 | DE |
12 | -1.1680001 | -36.477204872 | 3.202 | 3.38 | 2.0019999 | 78460 | 2.63650927 | DE |
26 | -1.8100001 | -47.0863709677 | 3.844 | 4.3019999 | 2.0019999 | 68952 | 3.06850062 | DE |
52 | -3.6500001 | -64.2153430683 | 5.684 | 5.686 | 2.0019999 | 65451 | 3.42986226 | DE |
156 | -19.7460001 | -90.6611574839 | 21.78 | 29.6 | 2.0019999 | 47892 | 10.41376627 | DE |
260 | -1.0610001 | -34.2811017771 | 3.095 | 29.6 | 2.0019999 | 50497 | 11.28226369 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions